Navigation Links
ThromboGenics NV Announces Business Update and Half Year Results 2009
Date:8/27/2009

,393 - 62,393 Net result 2009 (4,663) (4,663) (4,663) Conversion of warrants by 2,783 2,783 ThromboGenics Ltd Contribution in kind Thrombogenics Ltd shares 2,783 (2,783) Conversion of warrants by ThromboGenics NV 241 241 Exchange rate differences as a result of retranslation of foreign subsidiary 11 11 Share based payments 249 249 Fair-Value Adjustment Investments 72 72 Balance sheet at 30 Jun 2009 (48,622) 61,086 - 61,086

About ThromboGenics

ThromboGenics is a biotechnology company focused on the discovery and development of innovative medicines for the treatment of eye disease, vascular disease and cancer. The Company's lead product microplasmin is in Phase III clinical development for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent International; these include TB-402 (Anti-Factor VIII), a long acting anti-coagulant, and TB-403 (anti-PlGF) for cancer.

ThromboGenics has built strong links with the University of Leuven and the Flanders Institute for Biotechnology (VIB) and has exclusive rights to certain therapeutics developed at these institutions. ThromboGenics is headquartered in Leuven, Belgium. The Company is listed on Eurolist by Euronext Brussels unde
'/>"/>

SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ThromboGenics NV: Business Update
2. ThromboGenics Announces Business Update and 2008 Full Year Results
3. ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
4. ThromboGenics N.V.: Business Update
5. ThromboGenics Announces Half Year Results 2008
6. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
7. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
8. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
9. ThromboGenics N.V. - Business Update
10. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
11. ThromboGenics Announces 2007 Full Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... YORK , Nov. 26, 2014 The ... may indicate the company is looking to expand in ... further sales.  The healthcare market research firm says that  ... to Kalorama Information,s biennial survey of the IVD market ... and any change in its composition would likely affect ...
(Date:11/26/2014)... 2014 On January, 14, 2015, ... Washington D.C. science community to the UMBC campus for ... by the Protein Society, will take place from 9 ... 312. Through discussion, presentations and workshops, the free ... proteins, their role in the industry and the future ...
(Date:11/26/2014)... Whitehouse Laboratories is pleased to ... County (New Jersey) Chamber of Commerce as a ... organization in the North Jersey area, offers Whitehouse ... key clients in the pharmaceutical and biotechnology areas ... Membership enables Whitehouse Laboratories a higher level of ...
(Date:11/26/2014)... ADDISON, TX (PRWEB) November 25, 2014 ... age-defying skincare products, earned three prestigious MarCom Awards for ... , Nerium received a Platinum MarCom Award, the organization’s ... Real Event in St. Louis held in April of ... for more than 14,000 attendees. Additionally, Nerium was awarded ...
Breaking Biology Technology:Kalorama: Sale of Three Siemens Healthcare Units Raises Questions About Firm's IVD Future 2Whitehouse Laboratories Joins Morris County Chamber of Commerce 2Whitehouse Laboratories Joins Morris County Chamber of Commerce 3Nerium International™ Wins One Platinum, Two Gold MarCom Awards 2
... SoluLinK, Inc., a leader in,next-generation conjugation products ... of a new product, NanoLink(TM) Streptavidin Magnetic,Microspheres. ... of any commercially available polymer-encapsulated streptavidin,magnetic microsphere. ... throughput robotic applications where high biotin loads,must ...
... The automation of,transaction-based processing is finding new ... States. Foresight Corporation of Dublin, Ohio reports,growth ... installations of Transaction,Insight(R) - the leading platform ... techniques enable healthcare organizations to,cut operational costs ...
... May 28 NanoLogix, Inc. (Pink,Sheets: NNLX) a ... NanoLogix personnel will showcase company technology at ... in Boston, June 1-5 2008. The ASM,meeting is ... will be Dr. Sergey Gazenko and CEO Bret ...
Cached Biology Technology:SoluLinK Introduces NanoLink(TM) Streptavidin Magnetic Microspheres 2New Trend Sweeping Nation's Health Plans: Transaction Automation 2NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update 2
(Date:11/5/2014)... Kelly Redmond has dedicated his career to understanding ... a general audience. , As deputy director and ... at Nevada,s Desert Research Institute, Redmond has more ... application and dissemination of climate data to the ... Meeting in San Francisco on December 15-19, 2014 ...
(Date:11/4/2014)... Temple University School of Medicine announced today that ... initiative funded by the Bill & Melinda Gates ... Obstetrics, Gynecology and Reproductive Sciences; and Vice Chair ... School of Medicine will pursue an innovative global ... Biomarkers to Assess Fetal Neurodevelopment.", Grand Challenges Explorations ...
(Date:11/4/2014)... 2014) – A majority of Madagascar,s 101 species of ... serious consequences for the rainforests they call home. A ... impacts lemurs can have on rainforest tree populations, which ... have on the region,s rich biodiversity. , A large ... by lemurs. Lemurs in turn disperse the seeds ...
Breaking Biology News(10 mins):Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2Temple University School of Medicine receives Grand Challenges Explorations grant 2Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3
... respiratory syndrome (SARS) epidemic in China has lessons to ... other respiratory diseases, according to new research appearing in ... available online. , Hospitals were epicenters of SARS transmission ... hospitals with especially severe outbreaks, the researchers looked at ...
... is the ultimate enzyme responsible for all aerobic life ... a crucial component of the cellular machinery that generates ... might expect that scientists would have a clear understanding ... James P. Collman, professor emeritus of chemistry at Stanford ...
... epigenetic variations ensure that no two people are exactly ... cancers. Now, researchers have the tools and the ... cancer therapies, enabling them to create more effective therapies ... Meeting of the American Association for Cancer Research, researchers ...
Cached Biology News:Study identifies risk factors for spread of respiratory infections in hospitals 2Researchers create artificial enzyme that mimics the body's internal engine 2Researchers create artificial enzyme that mimics the body's internal engine 3Genes and biomarkers that allow doctors to choose the right therapy for the right patient 2Genes and biomarkers that allow doctors to choose the right therapy for the right patient 3Genes and biomarkers that allow doctors to choose the right therapy for the right patient 4Genes and biomarkers that allow doctors to choose the right therapy for the right patient 5Genes and biomarkers that allow doctors to choose the right therapy for the right patient 6
... reagents and supplies, for 10 chips, ... to perform protein analysis with 10 ... system. Supplied are 3 x 520 ... stain, 60 microliters Pro260 ladder (10-260 ...
...
... Fermentation System to achieve high experimental ... maximum information output 4 up ... with small-scale requirements provides users with ... E.coli, Pichia pastoris, yeast, fungi or ...
... preactivated with carbonyl diimidazole chemistry that covalently ... PS10 array contains the same binding chemistry ... an updated hydrophobic barrier coating. These arrays ... diameter spots spatially compatible with one column ...
Biology Products: